Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Survivin in Solid Tumors: Rati...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Survivin in Solid Tumors: Rationale for Development of Inhibitors
Show other versions (1)
Bibliographic Details
Main Authors:
Church, D
,
Talbot, D
Format:
Journal article
Published:
2012
Holdings
Description
Other Versions (1)
Similar Items
Staff View
Similar Items
Survivin in solid tumors: rationale for development of inhibitors.
by: Church, D, et al.
Published: (2012)
Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin
by: Janik John E, et al.
Published: (2011-04-01)
Quantitative Analysis of Survivin Protein Expression and Its Therapeutic Depletion by an Antisense Oligonucleotide in Human Lung Tumors
by: Olsen, A, et al.
Published: (2012)
Survivin Small Molecules Inhibitors: Recent Advances and Challenges
by: Najah Albadari, et al.
Published: (2023-02-01)
Editorial: Inhibitors of CDK family: New perspective and rationale for drug combination in preclinical models of solid tumors
by: Andrea Cavazzoni, et al.
Published: (2023-03-01)